该行指出，随着国际烟草龙头HNB产品登陆主流市场，公司相关新型烟草产品在新区域的销售有望贡 献增量；英国等欧洲地区有望向盈利能力更强的换弹式、开放式切换；美国电子烟执法力度显著加强， 合规产品份额恢复空间显著。建议关注思摩尔国际，公司雾化电子烟、HNB、雾化美容、雾化医疗等 多元业务逐步进入收获期，后续各类产品全球推出、多点催化可期。 消息面上，思摩尔国际近日公告，与亿纬锂能（300014）重续采购框架协议，自2026年1月至2028年12 月生效，协议采购亿纬锂能供应的电池产品。华福证券指出，制定采购协议主要考虑全球电子雾化产品 市场持续增长，公司相关产品订单有望持续增加。 思摩尔国际(06969)现涨超4%，截至发稿，涨4.6%，报12.96港元，成交额1.46亿港元。 ...

该行指出，随着国际烟草龙头HNB产品登陆主流市场，公司相关新型烟草产品在新区域的销售有望贡 献增量；英国等欧洲地区有望向盈利能力更强的换弹式、开放式切换；美国电子烟执法力度显著加强， 合规产品份额恢复空间显著。建议关注思摩尔国际，公司雾化电子烟、HNB、雾化美容、雾化医疗等 多元业务逐步进入收获期，后续各类产品全球推出、多点催化可期。 消息面上，思摩尔国际近日公告，与亿纬锂能重续采购框架协议，自2026年1月至2028年12月生效，协 议采购亿纬锂能供应的电池产品。华福证券指出，制定采购协议主要考虑全球电子雾化产品市场持续增 长，公司相关产品订单有望持续增加。 智通财经APP获悉，思摩尔国际(06969)现涨超4%，截至发稿，涨4.6%，报12.96港元，成交额1.46亿港 元。 ...

Core Viewpoint - China is the largest traditional tobacco market globally, while the US leads in the new tobacco market, with Japan and South Korea also holding significant shares in the new tobacco sector [1][3] Group 1: Market Dynamics - The traditional tobacco market is gradually shrinking, while the new tobacco market is experiencing rapid growth. In 2020, the market size of heated not-burn (HNB) products surpassed that of electronic cigarettes, establishing itself as the new leader in the new tobacco sector [2] - The US market currently leads in vaporized electronic cigarettes but has a significant gap in the HNB market. The resolution between PMI and BAT is expected to accelerate the development of the HNB market [3] - The regulatory environment in Europe is tightening for vaporized products while remaining stable for HNB, which may allow HNB to gradually capture a larger market share [3] Group 2: Product Landscape - The transition from traditional cigarettes to new tobacco products is driven by a dual focus on flavor and health, with new tobacco products offering significant harm reduction advantages and more diverse taste options [2] - Major multinational tobacco companies are actively investing in new tobacco products, which is likely to increase the penetration rate of these products in the market [2] Group 3: Compliance and Regulation - The structure of tobacco products and their acceptance in different countries is largely determined by national policies and regulations. Taxation influences the differing policy attitudes towards traditional and new tobacco products, while health concerns shape the regulatory stance on various new tobacco products [4] - Strict regulations and weak enforcement may lead to unintended consequences, such as the growth of the illegal electronic cigarette market [4] Group 4: Brand Landscape - The traditional tobacco market is highly concentrated, dominated by brands like Marlboro, Winston, and Camel. In the new tobacco sector, PMI and BAT hold leading market shares, but changes in policy and company strategies may alter the brand landscape [5] Group 5: Industry Chain - The tobacco supply chain includes essential materials for both cigarette and electronic cigarette production, such as cigarette labels, rolling paper, and electronic cigarette components like lithium batteries and control chips. Key listed companies in this supply chain include Jinjia Co., Dongfeng Co., and others [8]

Core Viewpoint - The new oral tobacco-free products are expected to have a favorable tax environment and less intense competition compared to vaping products, leading to the highest gross margins among new tobacco categories, attracting significant interest from international tobacco companies [1] Group 1: New Oral Tobacco Products - New oral tobacco products combine characteristics of heated non-combustible (HNB) and vaping products, addressing traditional oral tobacco's limitations such as high acceptance barriers and storage challenges [1] - The invention of new oral tobacco products has sparked global popularity, with the potential to replace traditional products and attract a new customer base through diverse flavor offerings [1] Group 2: Competitive Landscape - The market for new oral tobacco products has low entry barriers, but the market share remains concentrated among international tobacco companies, with no expected deterioration in market structure [2] - Factors supporting the current market structure include established customer bases and sales channels of traditional oral tobacco companies, a stable regulatory environment, and a short supply chain that enhances brand control over production [2] Group 3: Industry Catalysts - Philip Morris International's $16 billion acquisition of Swedish Match, the parent company of the leading brand ZYN, marks a significant direct investment in the new oral tobacco segment, reinforcing the industry's growth potential [3] - The FDA's approval of ZYN's 20 products for market release in January 2025, along with positive performance indicators from online distributors, further validates the industry's high growth outlook [3]

Core Viewpoint - The report from CICC indicates a downward adjustment in the net profit forecast for Smoore International (06969) for 2025 by 20% to 1.05 billion yuan, while the 2026 net profit forecast is raised by 11% to 1.88 billion yuan, reflecting a strong performance driven by HNB product sales [1] Group 1: Financial Performance - For the first three quarters of 2025, the company reported revenue of 10.21 billion yuan, a year-on-year increase of 21.8%, while the net profit attributable to shareholders was 810 million yuan, a year-on-year decrease of 23.8% [2] - Adjusted for stock incentive expenses, the net profit attributable to shareholders was 1.18 billion yuan, showing a slight year-on-year increase of 0.1% [2] - Quarterly net profit for 1Q, 2Q, and 3Q of 2025 was 200 million, 300 million, and 317 million yuan respectively, with year-on-year changes of -43.4%, +12.7%, and -16.4% [2] Group 2: Market Expansion and Product Performance - The Glo Hilo brand is expanding steadily in Japan and Poland, with the company positioned as a leader in flavor restoration, heating speed, and brand image [3] - The company anticipates continued growth in the European vaping market, driven by differentiated compliant products amid regulatory changes [3] - The open-system self-owned brand is leading in global market share, with expectations of continued year-on-year growth in 3Q25 [3] Group 3: Cost Structure and R&D Investment - Short-term profitability is impacted by the allocation of stock incentive expenses, while R&D investments remain high [4] - The company expects slight pressure on gross margins in the short term due to increased orders from small clients in the European vaping market and initial sales of HNB heating devices [4] - The net profit and adjusted net profit for 3Q25 showed year-on-year changes of -16.4% and +4% respectively [4] Group 4: Long-term Growth Prospects - The company is optimistic about the global expansion of HNB products, which is expected to drive performance in the coming years [5] - The combination of drug-device complex generic drug development and innovative drug collaborations is anticipated to lead to commercialization in the vaping medical sector, opening up long-term growth opportunities [5]

Investment Rating - The investment rating for the company is "Buy" and is maintained [12] Core Insights - Smoore International is the largest electronic vaporizer supplier globally, with growth potential unlocked by its technology positioning in HNB (Heated Not Burn) products [3][6] - The company's core business is recovering, benefiting from regulatory shifts in the industry and increasing market share among major clients [3][6] - The HNB business is expected to see significant growth, with a projected annual growth rate in the double digits and a current global penetration rate of less than 6% [3][7] Summary by Sections Introduction - Smoore International leverages its R&D advantages to launch HNB products, marking a new phase in the industry [6][17] - The company has transitioned from a pure equipment supplier to a tobacco business model, opening new growth avenues [6][17] Core Business - The HNB segment is poised for accelerated development, with a low penetration rate and high barriers to entry, indicating substantial growth potential [7][28] - The collaboration with British American Tobacco to launch Glo Hilo combines both companies' strengths, enhancing market competitiveness [7][28] Performance Outlook - The revenue-sharing model for Glo Hilo is expected to yield significant profits, with projections estimating annual profits for Smoore's HNB business to reach 6-7 billion RMB if market penetration increases [8][9] - The U.S. market presents a significant opportunity, with potential market size increases if HNB penetration rises to 15% [8][37] Traditional Business - The U.S. vaping market is expected to grow from $19.81 billion in 2021 to $27.03 billion in 2024, with a CAGR of 11% [9][20] - Regulatory changes in the U.S. are becoming more favorable, allowing for a recovery in the vaporizer business [9][20] Long-term Strategic Direction - The company is diversifying into medical and beauty vaporization, aiming for long-term growth across multiple sectors [10][19]

Summary of Smoore International Conference Call Company Overview - Smoore International primarily engages in the manufacturing of vaping products, serving major tobacco companies and domestic brands. The global market for vaping products is approximately $20 billion, with Smoore holding a significant position in this sector, including key clients like British American Tobacco [3][4]. Industry Challenges - Since 2021, Smoore has faced significant challenges, including: - The ban on fruit-flavored e-cigarettes in China since Q3 2022, leading to a drastic revenue decline from nearly 5 billion RMB [2][4]. - The illegal e-cigarette market in the U.S. capturing over 75% of market share, stalling growth for compliant products [4]. - The rise of disposable e-cigarettes in Europe, negatively impacting overall profit margins, with disposable e-cigarettes having a gross margin below 20% compared to over 50% for traditional products [5][7]. Current Development Logic - Smoore's current strategy focuses on: - Stabilizing its traditional vaping business by deepening ties with core clients and maintaining technological leadership [6]. - Actively expanding into the heated not burned (HNB) product category as a second growth avenue [2][6]. Market Dynamics - The U.S. market's compliance process is influenced by the regulation of illegal products. If fruit-flavored products are allowed, the compliant market demand could significantly expand [2][7]. - In Europe, the transition from disposable to refillable and open-system products is expected to enhance profitability, especially following bans on disposable e-cigarettes in the UK and France [10]. Key Factors for Market Expansion - The expansion of the compliant market hinges on the potential lifting of the fruit-flavored e-cigarette ban. Signals indicate that the FDA may relax restrictions, which could greatly boost demand [8][9]. HNB Market Potential - The global HNB market is valued at $38 billion, with rapid growth observed. North America has low penetration, but significant potential exists, especially with upcoming product launches from Philip Morris [11][12]. - Smoore's technological advantages in HNB products position it well for competition, with expectations of achieving a market share of around 30% in the mid-term [12]. Future Outlook - Smoore aims for a market capitalization target of 300 billion to 500 billion, driven primarily by HNB business growth and potential policy changes in the U.S. regarding vaping products [15]. - The company is also exploring new business avenues such as medical vaping, which holds considerable long-term potential [13][14]. Conclusion - Smoore International is navigating a challenging landscape with strategic focus areas in traditional vaping and HNB products. The company's future growth will depend on regulatory changes, market dynamics, and successful product launches.

Group 1 - The overall performance of HNB remains stable, benefiting from the launch of GloHilo, with Glo's market share in Sendai increasing by 1.5 percentage points [1][2] - In H1 2025, British American Tobacco's (BAT) new oral tobacco segment generated revenue of £470 million, a year-on-year increase of 38%, with sales of 5 billion pouches, up 42%, and a remarkable 206% growth in the U.S. market [1][3] - The U.S. new oral tobacco market exceeds £2 billion, expected to double in size over the next two years [3] Group 2 - The vaping market faced pressure in H1 2025, with BAT's vaping segment revenue declining by 15% year-on-year to £737 million, primarily due to illegal products in the U.S. and Canada, as well as market dynamics in Europe [1] - The launch of GloHilo has led to a 1.5 percentage point increase in market share in Sendai, with a successful entry into the high-end market [2] - BAT's heated tobacco segment generated £444 million in revenue in H1 2025, a slight increase of 1%, with sales of 10.1 billion sticks, up 2%, although declines in certain European markets offset growth [2] Group 3 - The U.S. market for new oral tobacco products is experiencing rapid growth, with the Velo brand capturing a market share of 17% by July 2025, following its launch in May [3] - The global HNB industry is entering a new product lifecycle phase, with major brands actively cultivating the market, indicating potential for accelerated industry expansion [4] - Recommendations are made for investing in companies with competitive product technology and supply chains, specifically British American Tobacco and Smoore International [4]

Investment Rating - Industry rating is maintained as "Outperform" [9] Core Insights - The report highlights that reduced-harm products and oral tobacco have become the core growth engines for British American Tobacco (BAT) and Philip Morris International (PMI) [1][3] - BAT's revenue for the first half of 2025 was £12.069 billion, a decrease of 2.2% year-on-year, but a 1.8% increase when excluding currency effects, primarily driven by recovery in the US market [1] - PMI reported a revenue of $19.4 billion for the first half of 2025, reflecting a year-on-year growth of 6.5% [3] Summary by Sections British American Tobacco (BAT) - BAT's operating profit for the first half of 2025 was £5.069 billion, a year-on-year increase of 19.1%, with an operating margin rising by 7.5 percentage points to 42.0% [1] - The diluted EPS for BAT was £2.036, up 1.6% year-on-year [1] - The number of consumers of BAT's reduced-harm products reached 30.5 million, an increase of 1.4 million year-on-year [2] - Modern oral products generated £470 million in revenue, a 38.1% increase year-on-year, with sales volume rising by 42.2% [2] Philip Morris International (PMI) - PMI's gross profit for the first half of 2025 was $13.1 billion, a 12.0% increase year-on-year [3] - The adjusted diluted EPS for PMI was $3.6, reflecting a year-on-year growth of 16.1% [3] - PMI's total shipment volume for the first half of 2025 was 387.9 billion units, a 2.5% increase year-on-year [4] - Reduced-harm product shipments reached 87.9 billion units, a 13.1% increase year-on-year, with 41.5 million consumers globally, an increase of 5 million [4] Regional Performance - In Japan, IQOS covered over 10 million legal-age consumers, with a shipment volume of 13.9 billion units in Q2 2025, a 3.2% increase year-on-year [6] - In the EU, IQOS shipments reached 6 billion units in Q2 2025, a 13.21% increase year-on-year [6] - In South Korea, IQOS shipments were 1.6 billion units in Q2 2025, a 12.8% increase year-on-year [6] Investment Opportunities - The report suggests focusing on the vaping supply chain, including companies like Smoore International and Yihua Healthcare, as well as the tobacco supply chain with companies like China Tobacco Hong Kong and China Boton [7]

Investment Rating - The industry is rated as "Buy" based on the expectation of an increase exceeding 15% in the next 3-6 months [6] Core Insights - The new tobacco industry continues to show strong growth trends, with PMI reporting a revenue increase of 7.1% and adjusted operating profit growth of 16.1% in Q2 2025 [1] - The HNB (Heated Not Burned) market is expected to grow significantly, particularly in the U.S., as the FDA's approval of JUUL products indicates a clear trend towards market expansion [2][3] - The overall HNB global market is on a continuous growth trajectory, with the U.S. market poised to contribute significantly to this growth [4] Summary by Sections Financial Performance - In Q2 2025, PMI achieved revenues of $10.1 billion and adjusted operating profits of $4.3 billion, reflecting year-on-year increases of 7.1% and 16.1% respectively [1] - New tobacco revenue in Q2 2025 reached $4.2 billion, a 15.2% increase year-on-year, with HNB sales volume also increasing by 9.2% to 38.8 billion sticks [1] Regulatory Environment - The FDA has approved JUUL's products for sale in the U.S., increasing the total number of approved vaping products from 34 to 39, indicating a more favorable regulatory environment for compliant products [2] - The FDA's focus on combating illegal products while facilitating the approval of compliant products suggests a dual approach to market regulation [3] Market Outlook - The HNB market in Europe is recovering from flavor bans, with PMI reporting double-digit growth in Q2 2025, indicating resilience in consumer demand [3] - The legal market for HNB products is expected to expand significantly, driven by regulatory changes and increasing consumer acceptance [4]